They found a significant decrease in BCR‐free survival for AA men as compared to CA men on univariable analysis, but not after adjustment for multiple covariates; no difference in aggressive PSA recurrence, metastasis‐free survival, prostate cancer‐specific survival, or overall death for AA men compared to CA men were observed. This evidence concerns the gene BCR and prostate cancer.